Top View
- Relevance As a Perioperative Marker in Pediatric Cardiac Surgery
- For Peer Review Only
- Copeptin – the Better Vasopressin
- Diabetes Insipidus: a Pragmatic Approach to Management
- Study About Role of Copeptin As a Diagnostic Marker And
- The Clinical Value of Copeptin in Acute Coronary Syndrome
- The Role of Copeptin As a Novel Cardiovascular Biomarker
- Copeptin in Patients with Heart Failure and Preserved Ejection Fraction: a Report from the Prospective Karen-Study
- Diagnostic Accuracy of Copeptin in the Differential Diagnosis Of
- Plasma Copeptin and Chronic Kidney Disease Risk in 3 European Cohorts from the General Population
- Changes in Copeptin Levels Before and 3 Months After Transsphenoidal
- Copeptin in Critically Ill Paediatric and Neonatal Intensive Care Patients
- Change in Plasma Copeptin Level After Acute Spontaneous Basal Ganglia Hemorrhage
- Prognostic Value of Elevated Copeptin and High-Sensitivity Cardiac Troponin T in Patients with and Without Acute Coronary Syndrome: the Contracs Study
- Copeptin Proavp
- Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated with Cardiovascular and All-Cause Mortality in Patients with Type 2 Diabetes (ZODIAC-31)
- Mouse Anti-Human Copeptin(N-Term) Monoclonal Antibody, Clone 5912 (CABT-L1116) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
- Risk Assessment of Sepsis Through Measurement of Proavp (Copeptin): a Secondary Analysis of the TRIAGE Study
- Pathophysiology of Copeptin in Kidney Disease and Hypertension Baris Afsar1,2
- The Role of Copeptin As a Diagnostic and Prognostic Biomarker for Risk
- Arginine Vasopressin, Plasma Copeptin Proavp, Plasma
- Copeptin, Troponin-I, Pro-BNP and Hs-CRP Levels in Diagnosing Acute
- Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All
- Copeptin Proavp, Plasma